" These are companies that are for-profit companies, and like you said, they have to answer to people. They have to develop drugs that will make money, and that’s not an antibiotic. " The profit motive is almost as blind a watchmaker as natural selection. We've built an environment which encourages bacteria to develop antibiotic resistance. Let's structure a pharmaceutical industry in which antibiotics are profitable…
http://www.nature.com/clpt/journal/v87/n3/pdf/clpt2009298a.p...
I attended a talk by an economist (whose name I don't recall, alas) who discussed establishing a futures market for drugs, with portfolios which would smooth out variabilities in what works and does not. It's pretty much the same as what you described.